Powell Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,270
Closed -$243K 123
2020
Q4
$243K Sell
2,270
-69
-3% -$6.63K 0.18% 75
2020
Q3
$205K Buy
2,339
+2
+0.1% +$188 0.18% 87
2020
Q2
$229K Buy
+2,337
New +$206K 0.22% 81
2020
Q1
Sell
-2,332
Closed -$207K 114
2019
Q4
$207K Buy
+2,332
New +$194K 0.22% 97

Other funds holding ABBV

Powell Investment Advisors's ABBV Position: Q1 2021 in Review

Powell Investment Advisors sold out of AbbVie (ABBV) in Q1 2021, closing a stake of 2,270 shares — an estimated $243K sold.

Powell Investment Advisors first reported a position in ABBV in Q4 2019 and held it in 4 quarters. The position peaked at $243K in Q4 2020. 2,614 funds tracked by Wall St. Rank hold ABBV as of Q1 2021.

  • Powell Investment Advisors reported no remaining AbbVie position as of Q1 2021 after selling out during the quarter.
  • Powell Investment Advisors sold 2,270 AbbVie shares in Q1 2021, an estimated $243K.
  • Powell Investment Advisors first reported a position in AbbVie in Q4 2019 and held it in 4 quarters.
  • Powell Investment Advisors's AbbVie position peaked at $243K in Q4 2020.
  • 2,614 funds tracked by Wall St. Rank held AbbVie as of Q1 2021.

Based on Powell Investment Advisors's 13F filing for Q1 2021, filed 14 Apr 2021.